Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

New Wegovy prescriptions have increased by about 33% since May 22, when a U.S. Food and Drug Administration ban on so-called ...

Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for ...

Managing type 2 diabetes isn't just about medicine—it's also about what's on your plate. Cook2DIAbeat is a new EU-supported ...

WASHINGTON– Today, AARP and the National Alliance for Caregiving released a sweeping new report that paints a stark picture of the state of family caregiving in America. Caregiving in the ...